Apremilast As an Off-Label Therapeutic Agent: A Comprehensive Review of Safety and Efficacy Data in the Literature for Combination Therapy and Inflammatory Dermatoses. J of Skin 2021, 5 (3), 203-227. https://doi.org/10.25251/skin.5.3.2.